Could the largest market for the new schizophrenia drug xanomeline and trospium chloride (Cobenfy) be in Alzheimer's disease ...

Stanford Medicine scientists are generating a periodic table of sorts for psychiatric disorders, providing a better ...

Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar ...

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

Your mental weakness could be your biggest career asset. Data collected from over 400,000 American and British workers has ...

Scientists at Stanford Medicine are advancing the understanding of schizophrenia by creating a "periodic table" for ...

In part one of a two part interview, Craig Chepke, MD, discusses how new schizophrenia drugs in development pipeline are expected to change the therapeutic landscape with Jonathan Meyer ...

Research suggests a link between schizophrenia and changes in the immune system, highlighting potential new pathways for ...

Researchers from the National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology ...

This new finding could help explain why some children develop neurodevelopmental disorders, such as autism or schizophrenia.

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...